Robert Yates, chief operating officer and member of the board of directors at Ortho Clinical Diagnostics (Ortho), possesses a wealth of experience in the diagnostics and life science industries and a strong background in integrating global businesses, building performance cultures, and delivering strategic business value. Yates joined Ortho from Merck KGaA, where he was president and CEO of EMD/Merck Millipore, the company's global life science division. At EMD Millipore, Yates finalized the complex transition of Millipore from a standalone company into one integrated, global life science division. Prior to EMD Millipore, Yates spent 23 years with Roche Diagnostics in a range of senior executive positions across a variety of business segments, functions, and geographies, overseeing product and portfolio development, global marketing, and business strategy and development. Most recently, he led Roche’s life science business based in Penzberg, Germany, and served as a member of the diagnostics executive committee. Previously, Yates was global head of business development and licensing. Yates joined Roche in Indianapolis, Indiana, in 1988 and held various roles in R&D, engineering, and operations before being appointed global head of business development and licensing, Basel, Switzerland, and a member of the diagnostics executive committee in 2003. He holds a bachelor of science degree in electrical engineering from Purdue University.

 clinical sciences